DYSPAREUNIA: CMS CLARIFICATION RESULTS IN EXPANDED TREATMENT AND COVERAGE UNDER MEDICARE PART D

ISSWSH is pleased to announce and recognize the Centers for Medicare and Medicaid Services (CMS) clarification of the statutory intent of “Prescription Drug Benefits” section 1860D-2(e)(2)(A) of the Social Security Act, stating that drugs for the treatment of moderate to severe dyspareunia (pain during sexual intercourse) due to menopause, are not excluded from Medicare Part D coverage when used consistent with this labeling.

 

ISSWSH, alongside the North American Menopause Society (NAMS), the American College of Obstetricians and Gynecologists (ACOG), and many other interested parties are committed to women’s health and particularly sexual health. James A. Simon, MD, President of ISSWSH, thanks these partners and commends CMS for this clarification that now allows women suffering from dyspareunia, to access expanded treatment options and get coverage under Medicare Part D.

View Press Release

Save the Date

ISSWSH Virtual Course 2020
November 6, 13, & 20, 2020  
Virtual
Registration open for on-demand viewing

ISSWSH Annual Meeting 2021
March 5-7, 2021   0 days left
Virtual
Visit the Meeting Website

ISSWSH Fall Course 2021
October 7-10, 2021   217 days left
DoubleTree Resort - Paradise Valley - Scottsdale, AZ
Visit the Course Website

ISSWSH Annual Meeting 2022
  March 3-6, 2022    367 days left
  Renaissance Dallas Hotel - Dallas, TX
Visit the Meeting Website

Latest Tweets

Join the social media campaign to raise HPV awareness! Post a pic of you & your loved ones on March 4 with the mess… https://t.co/Wf2uHjVg5y ISSWSH
Thank you to Cliovana for their bronze sponsorship and support of the #ISSWSH2021Virtual Meeting! https://t.co/A7YDEAjqos ISSWSH
EXCITING NEWS! Just in time for #ISSWSH2021Virtual we are thrilled to announce our latest manuscript on the managem… https://t.co/GgwWoTiaUc ISSWSH

Contact Details

ISSWSH Executive Office
14305 Southcross Dr
Suite 100
Burnsville, MN 55306
USA

Phone: +1 (952) 683 9025
Fax: +1 (952) 314 8212
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Follow Us

On Twitter
On Facebook
On Instagram